CN1308618A - 用于治疗胰岛素抗性和高血糖的噁唑芳基－羧酸 - Google Patents
用于治疗胰岛素抗性和高血糖的噁唑芳基－羧酸 Download PDFInfo
- Publication number
- CN1308618A CN1308618A CN99808363A CN99808363A CN1308618A CN 1308618 A CN1308618 A CN 1308618A CN 99808363 A CN99808363 A CN 99808363A CN 99808363 A CN99808363 A CN 99808363A CN 1308618 A CN1308618 A CN 1308618A
- Authority
- CN
- China
- Prior art keywords
- carbon atom
- alkyl
- hydrogen
- aryl
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7671098A | 1998-05-12 | 1998-05-12 | |
| US09/076710 | 1998-05-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1308618A true CN1308618A (zh) | 2001-08-15 |
Family
ID=22133734
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN99808363A Pending CN1308618A (zh) | 1998-05-12 | 1999-05-10 | 用于治疗胰岛素抗性和高血糖的噁唑芳基－羧酸 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1077958A1 (de) |
| JP (1) | JP2002514631A (de) |
| CN (1) | CN1308618A (de) |
| AU (1) | AU4073299A (de) |
| CA (1) | CA2331118A1 (de) |
| WO (1) | WO1999058511A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003027095A1 (en) * | 2001-09-26 | 2003-04-03 | Bayer Pharmaceuticals Corporation | Substituted 3-pyridyl tetrazoles as steroid c17,20 lyase inhibitors |
| WO2003048140A1 (fr) * | 2001-12-03 | 2003-06-12 | Japan Tobacco Inc. | Compose azole et utilisation medicinale de celui-ci |
| US7141592B2 (en) * | 2003-09-25 | 2006-11-28 | Wyeth | Substituted oxadiazolidinediones |
| AU2005236055B2 (en) | 2004-04-20 | 2011-10-06 | Transtech Pharma, Llc | Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators |
| RU2007106868A (ru) | 2004-08-23 | 2008-09-27 | Вайет (Us) | Оксазол-нафтиловые кислоты и их применение в качестве модуляторов ингибитора активатора плазминогена-1 (pai) для лечения тромбоза и сердечно-сосудистых заболеваний |
| JP2012501334A (ja) | 2008-08-29 | 2012-01-19 | トランス テック ファーマ，インコーポレイテッド | 置換アミノチアゾール誘導体、医薬組成物、および使用の方法 |
| CN106749169B (zh) * | 2016-11-07 | 2020-04-21 | 浙江工业大学 | 一种Ertiprotafib的手性制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58183676A (ja) * | 1982-04-19 | 1983-10-26 | Takeda Chem Ind Ltd | オキサゾ−ル誘導体 |
| CA2009470A1 (en) * | 1989-02-08 | 1990-08-08 | Yu Momose | Oxazole compounds and their use |
| US5591862A (en) * | 1993-06-11 | 1997-01-07 | Takeda Chemical Industries, Ltd. | Tetrazole derivatives, their production and use |
-
1999
- 1999-05-10 CA CA002331118A patent/CA2331118A1/en not_active Abandoned
- 1999-05-10 EP EP99924163A patent/EP1077958A1/de not_active Withdrawn
- 1999-05-10 WO PCT/US1999/010183 patent/WO1999058511A1/en not_active Application Discontinuation
- 1999-05-10 JP JP2000548315A patent/JP2002514631A/ja active Pending
- 1999-05-10 CN CN99808363A patent/CN1308618A/zh active Pending
- 1999-05-10 AU AU40732/99A patent/AU4073299A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1077958A1 (de) | 2001-02-28 |
| AU4073299A (en) | 1999-11-29 |
| CA2331118A1 (en) | 1999-11-18 |
| JP2002514631A (ja) | 2002-05-21 |
| WO1999058511A1 (en) | 1999-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1308621A (zh) | 用于治疗胰岛素抗性和高血糖的苯基氧代－乙酸 | |
| CN1308622A (zh) | 用于治疗胰岛素抗性和高血糖的联苯基氧代－乙酸 | |
| US6844358B2 (en) | Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia | |
| US6110963A (en) | Aryl-oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia | |
| KR101724161B1 (ko) | 세포내 칼슘을 조절하는 화합물 | |
| EP0343643A2 (de) | Arylmethylenderivate von Thiazolidinonen, Imidazolidinonen und Oxazolidininonen, nützlich als antiallergische Wirkstoffe und antiinflammatorische Wirkstoffe | |
| CA2618653A1 (en) | Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder | |
| US20100152241A1 (en) | Inhibitors of store operated calcium release | |
| KR20070055563A (ko) | 혈전증 및 심혈관 질병의 치료에 유용한 플라스미노겐활성화제 억제제 타입-1(ｐａｉ-1)의 조절제로서의옥사졸로-나프틸 산 | |
| KR20080056730A (ko) | 티아졸리논과 옥사졸리논 및 이의 ｐｔｐ１ｂ 억제제로서의용도 | |
| CN1176101A (zh) | N－(4－芳基－噻唑－2－基)－磺胺衍生物及其用途 | |
| KR20070045353A (ko) | 플라스미노겐 활성화제 억제제-1의 억제제로서티아졸로-나프틸 산 | |
| JP2007506781A (ja) | Ｐａｉ−１阻害剤としての置換オキサジアゾリジンジオン | |
| JP2007524653A (ja) | 置換ナフチルベンゾチオフェン酸 | |
| JPH11512095A (ja) | アルドース還元酵素阻害薬および抗高血糖症薬としてのフェノキシ酢酸 | |
| CN101932557A (zh) | 糖原磷酸化酶抑制剂化合物及其药物组合物 | |
| CN1308618A (zh) | 用于治疗胰岛素抗性和高血糖的噁唑芳基－羧酸 | |
| US6699896B1 (en) | Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia | |
| US6221902B1 (en) | Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia | |
| CN1308619A (zh) | (2－酰氨基噻唑－4－基)乙酸衍生物 | |
| CH653029A5 (fr) | Oxazolidine-2,4-diones substituees en position 5 a action hypoglycemique. | |
| CN1308620A (zh) | 用于治疗胰岛素抗性和高血糖的联苯基磺酰基芳基羧酸 | |
| JP4511172B2 (ja) | 肥満症および肥満症に随伴する疾患および／または二次疾患の治療および／または予防におけるトリフルオロアセチルアルキル置換されたフェニル誘導体、フェノール誘導体およびベンゾイル誘導体の使用 | |
| US6310081B1 (en) | Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia | |
| US5358964A (en) | Benzylidene-lactone and their thiocarbonyl analogs as inhibitors of proteoglycan degradation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |